Flex Pharma (FLKS) Tops Q1 EPS by 3c

Flex Pharma (NASDAQ: FLKS) reported Q1 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $179 thousand versus the consensus estimate of $280 thousand.

For earnings history and earnings-related data on Flex Pharma (FLKS) click here.

You May Also Be Interested In

• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance
• KeyBanc Downgrades Kite Realty Group (KRG) to Sector Weight
• Fabrinet (FN) Tops Q4 EPS by 29c, Beats on Revenue; Offers Guidance